Gábor Bánhegyi

Gábor Bánhegyi

Auto-generated profile, based on publicly available information

Gábor Bánhegyi

Department of Medical Chemistry, Molecular Biology, and Pathobiochemistry, Semmelweis University, Budapest 1094, Hungary

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMargita Márton
Margita Márton
NTNikolett Tihanyi
Nikolett Tihanyi
PGPál Gyulavári
Pál Gyulavári
GBGábor Bánhegyi
Gábor Bánhegyi
OKOrsolya Kapuy
Orsolya Kapuy
Oxidative stress results in activation of several signal transduction pathways controlled by the PERK-substrate NRF2 (nuclear factor erythroid 2-related factor 2); meanwhile the ongoing cell division cycle has to be blocked. It has been recently shown that Cyclin D1 got immediately down-regulated via PERK pathway in response to oxidative stress leading to cell cycle arrest. However, the effect of NRF2 on cell cycle regulation has not been explored yet. We aimed to reveal a crosstalk between PERK-substrate NRF2 and the key elements of cell cycle regulatory network upon oxidative stress using molecular biological techniques- Although Cyclin D1 level remained constant, its activity was blocked by various stoichiometric inhibitors (such as p15, p21 and p27) even at low level of oxidative stress. The activity of these CDK inhibitors completely disappeared, when the addition of oxidative agent was combined with silencing of either PERK or NRF2.This further confirms the important role of NRF2 in blocking Cyclin D1 with stoichiometric inhibitors at early stage of oxidative stress.

4 July 2008 in Planta
Verified
Journal Article
Closed access
PDF file
Andras SzarkaAndras Szarka
Andras Szarka
NHNele Horemans
Nele Horemans
SPSalvatore Passarella
Salvatore Passarella
ÁTÁkos Tarcsay
Ákos Tarcsay
FÖFerenc Örsi
Ferenc Örsi
GBGábor Bánhegyi
Gábor Bánhegyi

13 January 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CNCsilla E. Németh
Csilla E. Németh
ZNZsófia Nemoda
Zsófia Nemoda
PLPéter Lőw
Péter Lőw
PSPál Tamás Szabó
Pál Tamás Szabó
EHErzsébet Z. Horváth
Erzsébet Z. Horváth
EMEva Margittai
Eva Margittai
Ascorbate requiring Fe2+/2-oxoglutarate-dependent dioxygenases located in the nucleoplasm have been shown to participate in epigenetic regulation of gene expression via histone and DNA demethylation. Transport of dehydroascorbic acid is impaired in the endomembranes of fibroblasts from arterial tortuosity syndrome (ATS) patients, due to the mutation in the gene coding for glucose transporter GLUT10. We hypothesized that altered nuclear ascorbate concentration might be present in ATS fibroblasts, affecting dioxygenase activity and DNA demethylation. Therefore, our aim was to characterize the subcellular distribution of vitamin C, the global and site-specific changes in 5-methylcytosine and 5-hydroxymethylcytosine levels, and the effect of ascorbate supplementation in control and ATS fibroblast cultures. Diminished nuclear accumulation of ascorbate was found in ATS fibroblasts upon ascorbate or dehydroascorbic acid addition. Analyzing DNA samples of cultured fibroblasts from controls and ATS patients, a lower global 5-hydroxymethylcytosine level was found in ATS fibroblasts, which could not be significantly modified by ascorbate addition. Investigation of the (hydroxy)methylation status of specific regions in six candidate genes related to ascorbate metabolism and function showed that ascorbate addition could stimulate hydroxymethylation and active DNA demethylation at the PPAR-γ gene region in control fibroblasts only. The altered DNA hydroxymethylation patterns in patient cells both at the global level and at specific gene regions accompanied with decreased nuclear accumulation of ascorbate suggests the epigenetic role of vitamin C in the pathomechanism of ATS. The present findings represent the first example for the role of vitamin C transport in epigenetic regulation suggesting that ATS is a compartmentalization disease.

1 May 2018 in Plant Physiology and Biochemistry
Verified
Journal Article
Open access
OKOrsolya Kapuy
Orsolya Kapuy
PVP K Vinod
P K Vinod
GBGábor Bánhegyi
Gábor Bánhegyi
BNBéla Novák
Béla Novák
Ostreococcus tauri is the smallest free-living unicellular organism with one copy of each core cell cycle genes in its genome. There is a growing interest in this green algae due to its evolutionary origin. Since O. tauri is diverged early in the green lineage, relatively close to the ancestral eukaryotic cell, it might hold a key phylogenetic position in the eukaryotic tree of life. In this study, we focus on the regulatory network of its cell division cycle. We propose a mathematical modelling framework to integrate the existing knowledge of cell cycle network of O. tauri. We observe that feedback loop regulation of both G1/S and G2/M transitions in O. tauri is conserved, which can make the transition bistable. This is essential to make the transition irreversible as shown in other eukaryotic organisms. By performing sequence analysis, we also predict the presence of the Greatwall/PP2A pathway in the cell cycle of O. tauri. Since O. tauri cell cycle machinery is conserved, the exploration of the dynamical characteristic of the cell division cycle will help in further understanding the regulation of cell cycle in higher eukaryotes.